ASAM-magazine-Header

Features 

feature-stories-header

ASAM Hires Chief of Quality and Science

by ASAM Staff | Sep 05, 2018

The American Society of Addiction Medicine (ASAM) announced the hire of Maureen Boyle, PhD, as Chief Quality and Science Officer effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

She brings over ten years of experience in research, public health, and policy including positions with the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and, most recently, with the Addiction Policy Forum (APF). 

She holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).

###

 

BIOGRAPHY

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

Dr. Boyle brings over ten years of experience in research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), and, most recently, with the Addiction Policy Forum (APF).  

At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.  She oversaw many program areas including electronic heath records and health information exchange; privacy, confidentiality, and consent management practices; clinical quality measure development for behavioral health; and development and harmonization of behavioral health related data standards. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan, she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public, and she led development of research reports and other science communication materials. 

Most recently, as Chief Scientific Officer at APF, she communicated the science of addiction to diverse audiences and oversaw the development of the Addiction Resource Center and Helpline.   

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

Recent News

asam magazine

ASAM Hires Chief of Quality and Science

by ASAM Staff | Sep 05, 2018

The American Society of Addiction Medicine (ASAM) announced the hire of Maureen Boyle, PhD, as Chief Quality and Science Officer effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

She brings over ten years of experience in research, public health, and policy including positions with the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and, most recently, with the Addiction Policy Forum (APF). 

She holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).

###

 

BIOGRAPHY

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

Dr. Boyle brings over ten years of experience in research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), and, most recently, with the Addiction Policy Forum (APF).  

At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.  She oversaw many program areas including electronic heath records and health information exchange; privacy, confidentiality, and consent management practices; clinical quality measure development for behavioral health; and development and harmonization of behavioral health related data standards. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan, she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public, and she led development of research reports and other science communication materials. 

Most recently, as Chief Scientific Officer at APF, she communicated the science of addiction to diverse audiences and oversaw the development of the Addiction Resource Center and Helpline.   

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

ASAM Weekly Commentary

ASAM Weekly
by

Education

Review Course 2019

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians preparing for the ABPM Addiction Medicine Exam and primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders. 

Learn More

MOC Guide

Considering a career in Addiction Medicine or expanding your practice services?

Physicians who have a primary ABMS board may apply to take the ABPM Addiction Medicine exam to become or continue to be an addiction medicine specialist. This specific pathway will expire in 2021. Download the NEW ASAM Information Guide on Certification and MOC.

Click here

Opportunities

ASAM invites applications for the position of Editor-in-Chief of The ASAM Criteria

The ASAM Criteria® is the most widely used set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions. The ongoing advances in the addiction medicine field and lessons learned from real-world implementations of The ASAM Criteria call for more regular updates to these guidelines.

The Editor-in-Chief is expected to participate in the development and execution of a process for reviewing data from real-world implementations of the ASAM Criteria, including the ASAM CONTINUUM Software, and working with the editorial team to make empirically-driven revisions of the ASAM Criteria text.

Interested individuals are referred to the position description online at https://www.asam.org/about-us/jobs/editor-in-chief-the-asam-criteria for detailed information about qualifications, duties, and responsibilities.

Applications for this position must be received by close of business on June 6, 2019.

New Resources

JAM Podcast
 
In episode eleven of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Honora Englander, an Associate Professor of Medicine at Oregon Health & Science University and the Director and Principal Investigator of the Improving Addiction Care Team (IMPACT). In her recent article, Dr. Englander and her colleagues discuss using hospitalization as a "reachable moment" for highly vulnerable patients who are not engaged in treatment elsewhere and utilizing the IMPACT team in this process.

 

Journal of Addiction Medicine March/April 2019, Volume 13, Issue 2;

Drug court resources

Drug Court Resources

Tens of thousands of Americans access addiction pharmacotherapies through drug courts every year. New resources are now available. Created in partnership with the NADCP National Association of Drug Court Professionals.